Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:21 AM
Ignite Modification Date:
2025-12-25 @ 3:21 AM
NCT ID:
NCT02836405
Eligibility Criteria:
Inclusion Criteria at Boston Children's Hospital (children):
* For ASD group:
1. Clinical diagnosis of a disorder on the autism spectrum.
2. Assessment using the Autism Diagnostic Observation Schedule.
3. Assessment using the Autism Diagnostic Interview-Revised.
4. Children ages 6-16.
5. IQ\>70.
6. Verbal.
Inclusion Criteria at Beth Israel Deaconess Medical Center (adults):
* For ASD group:
1. Clinical diagnosis of a disorder on the autism spectrum.
2. Assessment using the Autism Diagnostic Observation Schedule.
3. Adults ages 21-65.
Exclusion Criteria:
* Intracranial pathology, cerebral palsy, history of severe head injury, significant dysmorphology, or known intracranial lesion.
* History of fainting spells of unknown or undetermined etiology.
* History of head injury resulting in prolonged loss of consciousness.
* History of seizures, diagnosis of epilepsy, or immediate family history of epilepsy.
* Any progressive neurological disorder or signs of intracranial pressure.
* Chronic uncontrolled medical conditions that may cause a medical emergency in case of a provoked seizure.
* Metal implants or devices.
* Substance abuse or dependence within the past six months.
* Certain prescription medications that decrease cortical seizure threshold.
* Pregnancy.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
65 Years
Study:
NCT02836405
Study Brief:
Protocol Section:
NCT02836405